No CrossRef data available.
Article contents
Dry-powder inhaler alternatives for chronic obstructive pulmonary disease patients post total laryngectomy
Published online by Cambridge University Press: 26 March 2025
Abstract
Objectives
Patients undergoing total laryngectomy who have chronic obstructive pulmonary disease are unable to use dry-powder inhalers due to the anatomical changes after surgery and are therefore at greater risk of post-operative pulmonary complications. In our practice, we identified a scarcity of resources available to help clinicians decide on a suitable alternative. Hence, we sought to provide a solution that would address this issue.
Methods
Within our head and neck centre, we worked with the respiratory team and specialist pharmacists to create a simple conversion table to help clinicians identify alternatives to dry-powder inhalers.
Results
A table was designed that shows which metered-dose inhalers when connected to a spacer and an infant face mask overlying the laryngeal stoma can be used.
Conclusion
Our table can be used as a resource by clinicians to improve the perioperative and long-term care of patients who cannot use dry-powder inhalers.
Keywords
Information
- Type
- Short Communications
- Information
- Copyright
- © The Author(s), 2025. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED.
Footnotes
Paul Koroma takes responsibility for the integrity of the content of the paper
Presented at Billroth Memorial Laryngectomy Conference in Amsterdam, 23–24 November 2023
References
Sylvester, MJ, Marchiano, E, Park, RCW, Baredes, S, Eloy, JA. Impact of chronic obstructive pulmonary disease on patients undergoing laryngectomy for laryngeal cancer. Laryngoscope 2017;127:417–23CrossRefGoogle ScholarPubMed
British Thoracic Society Position Statement Environment and Lung Health 2020. In: https://www.brit-thoracic.org.uk/about-us/our-strategic-priorities/environment-and-lung-health/#:∼:text=Our%20Position%20Statement%20on%20Air,mitigate%20the%20impact%20of%20air [22 May 2024]Google Scholar
Nandapalan, V, Currey, M, Jones, TM. A modified spacer device for inhalational drug therapy for chronic bronchitis/asthma in laryngectomised patients. Clin Otolaryngol Allied Sci 2000;25:118–19CrossRefGoogle ScholarPubMed
Mirza, S, Hopkinson, L, Malik, TH, Willatt, DJ. The use of inhalers in patients with tracheal stomas or tracheostomy tubes. J Laryngol Otol 1999;113:762–4CrossRefGoogle ScholarPubMed
NICE guideline [NG80] Asthma: diagnosis, monitoring and chronic asthma management. In: https://www.nice.org.uk/guidance/ng80/resources/inhaled-corticosteroid-doses-pdf-4731528781 [22 May 2024]Google Scholar
NICE Clinical Knowledge Summaries Chronic obstructive pulmonary disease: inhaled corticosteroids. In: https://cks.nice.org.uk/topics/chronic-obstructive-pulmonary-disease/prescribing-information/inhaled-corticosteroids/ [22 May 2024]Google Scholar
Ackerstaff, AH, Hilgers, FJ, Meeuwis, CA, Knegt, PP, Weenink, C. Pulmonary function pre- and post-total laryngectomy. Clin Otolaryngol Allied Sci 1999;24:491–4CrossRefGoogle ScholarPubMed
Venkatesan, P. GOLD COPD report: 2025 update. Lancet Respir Med 2025;13:e7–e8.CrossRefGoogle ScholarPubMed
Koroma et al. supplementary material
Koroma et al. supplementary material
File
1.5 MB